# Vijay Patil

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/vijay-patil/

## Facts

| Field | Value |
| --- | --- |
| Citations | 4,409 |
| Field | Head and Neck Cancer Studies |
| h-index | 31 |
| i10-index | 89 |
| Last Known Institution | Homi Bhabha National Institute |
| OpenAlex ID | https://openalex.org/A5031219890 |
| ORCID iD | 0000-0002-7691-3995 |
| Works | 379 |

## Researcher papers

- [Gefitinib Versus Gefitinib Plus Pemetrexed and Carboplatin Chemotherapy in <i>EGFR</i>-Mutated Lung Cancer](https://scholariq.org/papers/gefitinib-versus-gefitinib-plus-pemetrexed-and-carboplatin-chemotherapy-in-i/)
- [Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority Trial](https://scholariq.org/papers/once-a-week-versus-once-every-3-weeks-cisplatin-chemoradiation-for-locally/)
- [Low-Dose Immunotherapy in Head and Neck Cancer: A Randomized Study](https://scholariq.org/papers/low-dose-immunotherapy-in-head-and-neck-cancer-a-randomized-study/)
- [Neoadjuvant chemotherapy followed by surgery in very locally advanced technically unresectable oral cavity cancers](https://scholariq.org/papers/neoadjuvant-chemotherapy-followed-by-surgery-in-very-locally-advanced/)
- [A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancer](https://scholariq.org/papers/a-randomized-phase-3-trial-comparing-nimotuzumab-plus-cisplatin/)
- [Lung cancer in the Indian subcontinent](https://scholariq.org/papers/lung-cancer-in-the-indian-subcontinent/)
- [Low-cost oral metronomic chemotherapy versus intravenous cisplatin in patients with recurrent, metastatic, inoperable head and neck carcinoma: an open-label, parallel-group, non-inferiority, randomised, phase 3 trial](https://scholariq.org/papers/low-cost-oral-metronomic-chemotherapy-versus-intravenous-cisplatin-in-patients/)
- [A prospective randomized phase II study comparing metronomic chemotherapy with chemotherapy (single agent cisplatin), in patients with metastatic, relapsed or inoperable squamous cell carcinoma of head and neck](https://scholariq.org/papers/a-prospective-randomized-phase-ii-study-comparing-metronomic-chemotherapy-with/)
- [Prospective Phase II Open-Label Randomized Controlled Trial to Compare Mandibular Preservation in Upfront Surgery With Neoadjuvant Chemotherapy Followed by Surgery in Operable Oral Cavity Cancer](https://scholariq.org/papers/prospective-phase-ii-open-label-randomized-controlled-trial-to-compare/)
- [Results of Phase III Randomized Trial for Use of Docetaxel as a Radiosensitizer in Patients With Head and Neck Cancer, Unsuitable for Cisplatin-Based Chemoradiation](https://scholariq.org/papers/results-of-phase-iii-randomized-trial-for-use-of-docetaxel-as-a-radiosensitizer/)
- [Repeat biopsy in epidermal growth factor receptor mutation-positive nonsmall cell lung cancer: Feasibility, limitations, and clinical utility in Indian patients](https://scholariq.org/papers/repeat-biopsy-in-epidermal-growth-factor-receptor-mutation-positive-nonsmall/)

## Researcher topics

- [Head and Neck Cancer Studies](https://scholariq.org/topics/head-and-neck-cancer-studies/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)
- [Lung Cancer Diagnosis and Treatment](https://scholariq.org/topics/lung-cancer-diagnosis-and-treatment/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Oral health in cancer treatment](https://scholariq.org/topics/oral-health-in-cancer-treatment/)

## Researcher university

- [Homi Bhabha National Institute](https://scholariq.org/institutions/homi-bhabha-national-institute/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.